Neuland Laboratories Limited NEULANDLAB.BO Stock
Neuland Laboratories Limited Price Chart
Neuland Laboratories Limited NEULANDLAB.BO Financial and Trading Overview
Neuland Laboratories Limited stock price | 6639 INR |
Previous Close | 2994.2 INR |
Open | 3029.95 INR |
Bid | 2927.2 INR x 0 |
Ask | 2932.6 INR x 0 |
Day's Range | 2915.45 - 3029.95 INR |
52 Week Range | 1007.7 - 3125 INR |
Volume | 4.05K INR |
Avg. Volume | 10.49K INR |
Market Cap | 37.67B INR |
Beta (5Y Monthly) | 1.021232 |
PE Ratio (TTM) | 23.023054 |
EPS (TTM) | 247.12 INR |
Forward Dividend & Yield | 10 (0.33%) |
Ex-Dividend Date | July 11, 2023 |
1y Target Est | 703 INR |
NEULANDLAB.BO Valuation Measures
Enterprise Value | 39.67B INR |
Trailing P/E | 23.023054 |
Forward P/E | 65.93083 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.1621363 |
Price/Book (mrq) | 3.7888691 |
Enterprise Value/Revenue | 3.33 |
Enterprise Value/EBITDA | 14.592 |
Trading Information
Neuland Laboratories Limited Stock Price History
Beta (5Y Monthly) | 1.021232 |
52-Week Change | 186.26% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3125 INR |
52 Week Low | 1007.7 INR |
50-Day Moving Average | 2424.6 INR |
200-Day Moving Average | 1766.82 INR |
NEULANDLAB.BO Share Statistics
Avg. Volume (3 month) | 10.49K INR |
Avg. Daily Volume (10-Days) | 6.02K INR |
Shares Outstanding | 12.83M |
Float | 5.92M |
Short Ratio | N/A |
% Held by Insiders | 39.63% |
% Held by Institutions | 22.63% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 10 |
Trailing Annual Dividend Yield | 0.33% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.0392 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 13.72% |
Operating Margin (ttm) | 18.39% |
Gross Margin | 48.47% |
EBITDA Margin | 22.82% |
Management Effectiveness
Return on Assets (ttm) | 9.24% |
Return on Equity (ttm) | 17.82% |
Income Statement
Revenue (ttm) | 11.91B INR |
Revenue Per Share (ttm) | 928.45 INR |
Quarterly Revenue Growth (yoy) | 58.69% |
Gross Profit (ttm) | N/A |
EBITDA | 2.72B INR |
Net Income Avi to Common (ttm) | 1.64B INR |
Diluted EPS (ttm) | 127.52 |
Quarterly Earnings Growth (yoy) | 288.19% |
Balance Sheet
Total Cash (mrq) | 591.04M INR |
Total Cash Per Share (mrq) | 46.07 INR |
Total Debt (mrq) | 1.28B INR |
Total Debt/Equity (mrq) | 12.92 INR |
Current Ratio (mrq) | 1.733 |
Book Value Per Share (mrq) | 774.875 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.37B INR |
Levered Free Cash Flow (ttm) | 1.43B INR |
Profile of Neuland Laboratories Limited
Country | India |
State | N/A |
City | Hyderabad |
Address | Phoenix IVY Building |
ZIP | 500033 |
Phone | 91 40 6761 1600 |
Website | https://www.neulandlabs.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
Q&A For Neuland Laboratories Limited Stock
What is a current NEULANDLAB.BO stock price?
Neuland Laboratories Limited NEULANDLAB.BO stock price today per share is 6639 INR.
How to purchase Neuland Laboratories Limited stock?
You can buy NEULANDLAB.BO shares on the BSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neuland Laboratories Limited?
The stock symbol or ticker of Neuland Laboratories Limited is NEULANDLAB.BO.
Which industry does the Neuland Laboratories Limited company belong to?
The Neuland Laboratories Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Neuland Laboratories Limited have in circulation?
The max supply of Neuland Laboratories Limited shares is 12.83M.
What is Neuland Laboratories Limited Price to Earnings Ratio (PE Ratio)?
Neuland Laboratories Limited PE Ratio is 26.86549200 now.
What was Neuland Laboratories Limited earnings per share over the trailing 12 months (TTM)?
Neuland Laboratories Limited EPS is 247.12 INR over the trailing 12 months.
Which sector does the Neuland Laboratories Limited company belong to?
The Neuland Laboratories Limited sector is Healthcare.